Partnering For Analytical Excellence

This document describes a comprehensive analytical development framework designed to support pharmaceutical and biotechnology programs throughout the entire drug development lifecycle. It highlights capabilities in method development, validation, and lifecycle management for both drug substances and drug products, including impurity profiling, dissolution testing, and stability studies. Advanced analytical tools such as chromatography, mass spectrometry, and spectroscopy are used alongside specialized services like extractables and leachables testing, nitrosamine analysis, and oligonucleotide characterization. The content emphasizes strong regulatory alignment with global guidelines, ensuring submission-ready data and compliance with international standards. Digital quality systems and data integrity principles enable traceable, audit-ready operations, while large-scale stability infrastructure supports long-term and accelerated studies. Additionally, integrated workflows and cross-functional collaboration enhance efficiency, reduce risk, and accelerate development timelines. Overall, the document presents a robust, science-driven approach to ensuring accuracy, safety, and reliability in analytical processes.